O ne of the major causes of hepatic sinusoidal obstruction syndrome (HSOS) is the intake of pyrrolizidine alkaloid (PA)-containing herbals. 1 Gynura segetum is one of the most common herbal medicines containing PAs. The diagnosis of PA-induced HSOS is based on a history of taking PA-containing herbs and a classical triad of weight gain, painful hepatomegaly, and jaundice. 2, 3 However, clinical presentation of PA-induced HSOS may resemble other liver diseases. Therefore, the history of PA exposure is essential for the definition of PA-induced HSOS. In clinical practice, PA exposure is always obscure because of variability of the herb components, mislabeling or misidentification of herbs, and outright contamination. To date, reports describing magnetic resonance imaging (MRI) features in PA-induced HSOS have been based on small numbers of patients. 4 The purpose of this study is to retrospectively describe the features of dynamic contrast-enhanced (DCE) MRI in a larger group of PA-induced HSOS.
Materials and Methods
Ninety consecutive patients with PA-induced HSOS were evaluated for our study from September 2010 to May 2016; all cases were associated with Gynura segetum-containing PA. Previously described diagnostic criteria for Gynura segetum-induced HSOS were used. [2] [3] [4] Enrolled patients (n ¼ 39) had undergone DCE MRI scan and had image data available for review. Data including age, gender, presenting symptoms and signs, medical history, laboratory results, imaging findings, and pathologic changes were recorded. All MRIs were independently reviewed by 2 experienced radiologists. We assessed the distribution of heterogeneous hypointensity. The severity of heterogeneous hypointensity was evaluated according to hypointense abnormality 5, 6 (4-point scale: 1 ¼ equivocal; 2 ¼ mild; 3 ¼ moderate; 4 ¼ severe) and the proportion of hypointense area (3-point scale: mild, <33% of the total area was involved; moderate, 33%-67% was involved; and severe, >67% was involved).
Results
Abnormal liver function tests in PA-induced HSOS included alanine aminotransferase (80.56%), aspartate aminotransferase (AST) (75.68%), alkaline phosphatase (38.89%), g-glutamyltransferase (94.59%), total bilirubin (80.56%), albumin (80.56%), and prothrombin time (66.67%). Common MRI findings (Figure 1 ) included ascites (100%), heterogeneous hypointensity (100%), narrowing of inferior vena cava (97.44%), periportal edema (97.44%), gallbladder wall thickening (92.31%), hepatomegaly (61.54%), abnormal hepatic vein (narrowing of right hepatic vein, 61.54%; invisible contrast materials in right hepatic vein, 38.46%), and pleural effusion (58.97%). Of these findings, hypointense heterogeneity in the portal-venous phase was a distinct feature. The most common distribution of hypointense heterogeneity was diffuse (76.92%) and right lobar predominance (17.95%). We graded the severity of heterogeneous hypointensity according to hypointense abnormality, and found 92.31% of the patients were scored as graded 4 (severe). Thus, we scored the severity of heterogeneous hypointensity using the proportion of hypointense area in 3 different sections (the level of right hepatic vein, left sagittal section of portal vein, and portal vein trunk); and graded the results as mild in 7 cases (17.95%), moderate in 25 cases (64.10%), and severe in 7 cases (17.95%). Pearson correlation test demonstrated alanine aminotransferase level (r ¼ 0.409; P ¼ .02), AST level (r ¼ 0.509; P ¼ .003), albumin concentration (r ¼ -0.366; P ¼ .039), prothrombin time (r ¼ 0.461; P ¼ .012), and AST to platelet ratio index (r ¼ 0.459; P ¼ .011) were significantly associated with the severity of heterogeneous hypointensity. Interestingly, inhomogeneous enhancement around hepatic veins named "claw-shaped" enhancement was observed in most patients (74.36%) (Figure 1 ). Hypointense in SWI and T2* imaging was observed in PA-induced HSOS, and the distribution of hypointense in SWI and T2* imaging was consistent with that of heterogeneous hypointensity on DCE MRI scan.
Discussion
In this retrospective study, PA-induced HSOS displayed distinct features on MRI: heterogeneous hypointensity, claw-shaped enhancement, and hypointense in SWI and T2* imaging. Heterogeneous hypointensity was a distinct sign, and the severity of heterogeneous hypointensity correlated with liver function tests and a noninvasive marker of fibrosis (AST to platelet ratio index). In PA-induced HSOS, venules adjacent to main branches of hepatic vein were more often patent, so liver parenchyma around main branches of hepatic vein received better blood perfusion. This differential perfusion resulted in claw-shaped enhancement (inhomogeneous enhancement around hepatic veins). In PA-induced HSOS, macrophages engulf the extravasated erythrocytes in the space of Disse, and then degrade it to produce hemosiderin. T2* imaging and SWI detect paramagnetic substances, such as hemoglobin and hemosiderin. Therefore, hypointense SWI and T2* imaging was observed and was a useful adjunct to DCE MRI in detecting HSOS. Interestingly, we found variability in imaging signs of HSOS on MRI scan relative to previous studies 2,4-8 and attribute this to differing etiologies and the severity of HSOS between studies. In conclusion, MRI provides a useful technique to differentiate HSOS from other liver diseases.
